Viewing Study NCT04934800


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-05-09 @ 4:22 PM
Study NCT ID: NCT04934800
Status: COMPLETED
Last Update Posted: 2025-06-24
First Post: 2021-06-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
Sponsor:
Organization: